Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × osimertinib × Thoracic × Clear all

Status

Sponsor Class

OTHER 109 INDUSTRY 88 NIH 5 NETWORK 3 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 12 Carboplatin 11 Pemetrexed 10 Drug Therapy 9 Gemcitabine 8 Gefitinib 8 Docetaxel 7 camrelizumab 5 Radiotherapy 5 Paclitaxel 5 Nivolumab 5 Irinotecan 5 Erlotinib Hydrochloride 5 tislelizumab 4 apatinib 4 Simvastatin 4 Endostatins 4 Bevacizumab 4 pembrolizumab 3 endostar protein 3 Platinum Compounds 3 Etoposide 3 toripalimab 2 surufatinib 2 olaparib 2 durvalumab 2 atezolizumab 2 anlotinib 2 Topotecan 2 Thalidomide 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05421936 2023-11-22

UNICORN

Sheba Medical Center

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡